Hyundai to release allergen screen topical gel

Published: 2010-10-01 06:56:00

Updated: 2010-10-01 06:56:00

Hyundai Pharm said it has recently signed an exclusive license agreement with Nitto Pharmaceutical Industries, Ltd., to distribute NasalGuard, a topical gel used to prevent the inhalation of airborne allergens, in Korea.

Developed by the U.S. based Trutek Corp., NasalGuard is adrug-free invisi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK